None listed
Conditions
Interventions
Intervention1: Eupatorium Perfoliatum 30: Eupatorium Perfoliatum 30, 4 pills, once a week for 10 weeks plus IEC (Information, education and communication) through information pamphlets on mosquito bor
Sponsors
Central Council for Research in Homoeopathy
Eligibility
Inclusion criteria
Inclusion criteria: 1.Healthy individuals of either sex aged 1 year and above living in the same community 2.Informed consent by the family head 3.No symptom of dengue and chikungunya at the time of taking medicine.
Exclusion criteria
Exclusion criteria: 1.Symptoms of dengue like illness/ fever in last 7 days 2.Pregnant women and lactating mother 3.Child below age of 1 year. 4.Individuals taking other preventive medicines for dengue & chikungunya 5.Patients with malignancy, immunocompromised state, life threatening diseases, end stage diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| a.Changes in incidence of dengue fever between the groups. b.Changes in incidence of chikungunya fever between the groups. Timepoint: 1.Changes in incidence of dengue fever between the groups at the end of three month. 2.Changes in incidence of chikungunya fever between the groups at the end of 3 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| a.To assess and compare the duration of symptoms in participants those who suffered from dengue fever between the groups. b. To assess and compare the duration of symptoms in participants those who suffered from chikungunya fever between the groups.Timepoint: a.To assess and compare the duration of symptoms in participants those who suffered from dengue fever between the groups on daily basis. b. To assess and compare the duration of symptoms in participants those who suffered from chikungunya fever between the groups on daily basis. | — |
Countries
India
Contacts
Public ContactDr D B Sarkar
CCRH
Outcome results
None listed